Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Sofia Pitsigavdaki's publication output changed over time?
ScholarIQpublication output · 2018–2025
Output declined50% over the shown period — from 2 works in 2018 to 1 in 2025.
2
1
3
1
2
1
201820212022202320242025
What are the most-cited papers on Sofia Pitsigavdaki?
ScholarIQmost cited works
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antônio Carlos Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T. Boumpas, Alessandra Bortoluzzi, George Βertsias
Annals of the Rheumatic Diseases. 202438 CitationsOPEN ACCESS
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
Myrto Nikoloudaki, Dionysis Nikolopoulos, Sofia Koutsoviti, Irini Flouri, Noemin Kapsala, Argyro Repa, Pelagia Katsimbri, Evangelos Theotikos, Sofia Pitsigavdaki, K. Pateromichelaki, Antonios Bertsias, Antonia Elezoglou, Prodromos Sidiropoulos, Antonis Fanouriakis, Dimitrios T. Boumpas, George Βertsias
Frontiers in Immunology. 202327 CitationsOPEN ACCESS
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with ‘difficult to treat’ rheumatoid arthritis
Antonios Bertsias, Irini Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Sofia Pitsigavdaki, George Βertsias, Prodromos Sidiropoulos
S2738706341. 202424 CitationsOPEN ACCESS
Lower lobe pneumonia presenting as singultus (hiccups).
Stamatis Karakonstantis, Sofia Pitsigavdaki, D Korela, Despoina Galani
PubMed. 201821 CitationsOPEN ACCESS
Lupus Nephritis: Improving Treatment Options
Myrto Kostopoulou, Sofia Pitsigavdaki, George Βertsias
Drugs. 202221 Citations
Related on ScholarIQ
University of Crete
Institution
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression
Paper
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
Paper
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with ‘difficult to treat’ rheumatoid arthritis
Paper
Lower lobe pneumonia presenting as singultus (hiccups).
Paper
Lupus Nephritis: Improving Treatment Options
Paper